PR Newswire PharmaOriginal article
A $10 Generic Cut LDL Cholesterol by 53%. Why Are Employers Being Pushed Toward $700-a-Month Drugs?
Data ReadoutpositiveGeneric cholesterol-lowering drugEzetimibePCSK9 inhibitorsPositive
AI Analysis
Summary
TOWARD Health research demonstrates a $10 generic drug reduced LDL cholesterol by 53%, performing significantly better than ezetimibe and comparably to PCSK9 inhibitors, raising questions about pharmaceutical pricing practices.
Outcome Details
Generic drug achieved 53% LDL reduction, nearly three times conventional ezetimibe response and within PCSK9 inhibitor trial range
Importance:5/10
Sentiment:
0.70
cholesterolLDL reductiongeneric drugcost effectivenessdrug pricingresearch
Read the original article
Published by PR Newswire Pharma on August 25, 2026 3:45 PM